Cargando…

LncRNA LINC01537 Promotes Gastric Cancer Metastasis and Tumorigenesis by Stabilizing RIPK4 to Activate NF-κB Signaling

SIMPLE SUMMARY: At the time of diagnosis, many gastric cancer (GC) patients were often found to have reached an advanced stage, with a five-year overall survival rate of less than 30%. Therefore, a better understanding of the underlying mechanism of GC metastasis is essential for developing novel an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Guang-Yu, Tan, Jia-Nan, Huang, Jing, Zhou, Sheng-Ning, Yu, Jin-Hao, Zhong, Lin, Hou, Dong, Zhi, Shi-Lin, Zeng, Jin-Tao, Li, Hong-Ming, Zheng, Chu-Lian, Yang, Bin, Han, Fang-Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657364/
https://www.ncbi.nlm.nih.gov/pubmed/36358656
http://dx.doi.org/10.3390/cancers14215237
Descripción
Sumario:SIMPLE SUMMARY: At the time of diagnosis, many gastric cancer (GC) patients were often found to have reached an advanced stage, with a five-year overall survival rate of less than 30%. Therefore, a better understanding of the underlying mechanism of GC metastasis is essential for developing novel and effective treatments. The aim of this study was to assess the role of lncRNAs in GC metastasis. We confirmed that LINC01537 promoted the proliferation, invasion, and migration of GC cells in vitro, and promoted tumorigenesis and metastasis in vivo. Mechanistically, LINC01537 stabilizes RIPK4 by reducing the binding of RIPK4 to TRIM25, and reducing its ubiquitination degradation, thereby promoting the expression of the NF-κB signaling pathway. ABSTRACT: Many studies reported that long noncoding RNAs (lncRNAs) play a critical role in gastric cancer (GC) metastasis and tumorigenesis. However, the underlying mechanisms of lncRNAs in GC remain unexplored to a great extent. LINC01537 expression level was detected using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC). Its biological roles in GC were then investigated using functional experiments. In order to investigate the underlying mechanism of LINC01537 in GC, RNA pull-down, RNA immunoprecipitation, and ubiquitination assays were performed. LINC01537 was significantly overexpressed in GC tissues and associated with a poor prognosis. Functional experimental results revealed that LINC01537 promoted the proliferation, invasion, and migration of GC cells. The animal experiments revealed that LINC01537 promoted tumorigenesis and metastasis in vivo. Mechanistically, LINC01537 stabilizes RIPK4 by reducing the binding of RIPK4 to TRIM25 and reducing its ubiquitination degradation, thereby promoting the expression of the NF-κB signaling pathway. According to our findings, the LINC01537-RIPK4-NF-κB axis promoted GC metastasis and tumorigenesis.